{
  "created_at": "Sat Nov 06 15:44:37 +0000 2021",
  "id_str": "1456992284797513741",
  "full_text": "The maker of a promising drug to treat ALS, or Lou Gehrig’s disease, submitted an application to the FDA for approval https://t.co/uAa8ewm82H",
  "display_text_range": [
    0,
    141
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/uAa8ewm82H",
        "expanded_url": "https://on.wsj.com/3BKEAwJ",
        "display_url": "on.wsj.com/3BKEAwJ",
        "indices": [
          118,
          141
        ]
      }
    ]
  },
  "user": {
    "name": "The Wall Street Journal",
    "screen_name": "WSJ",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/971415515754266624/zCX0q9d5_normal.jpg"
  },
  "retweet_count": 25,
  "favorite_count": 113,
  "possibly_sensitive": false,
  "original_created_at": "Sat Nov 06 14:30:04 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "ALS（ルー・ゲーリッグ病）の有望な治療薬のメーカーが、FDAに承認申請を行いました。https://t.co/uAa8ewm82H。"
    },
    {
      "locale": "zh",
      "full_text": "一种治疗ALS（或称卢伽雷氏症）的有希望的药物的制造商向美国食品和药物管理局提交了一份申请，要求批准https://t.co/uAa8ewm82H。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "一種治療ALS（或稱盧伽雷氏症）的有希望的藥物的製造商向美國食品和藥物管理局提交了一份申請，要求批准https://t.co/uAa8ewm82H。"
    }
  ]
}